Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Biochemical and Biophysical Research Communications
|
May 31, 1988
Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2b
G E Fronko, R J Suhadolnik, E C Vonderheid, et al.
Biochemistry
|
November 3, 1987
Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease
K Karikó, R W Sobol, L Suhadolnik, et al.
The Journal of Biological Chemistry
|
March 17, 1995
Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2',5'-oligoadenylate derivatives
R W Sobol, E E Henderson, N Kon, et al.
Biochemistry
|
November 16, 1993
HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates
R W Sobol, W L Fisher, N L Reichenbach, et al.
In Vivo (Athens, Greece)
|
July 1, 1994
Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome
R J Suhadolnik, N L Reichenbach, P Hitzges, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1989
Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro
D C Montefiori, R W Sobol, S W Li, et al.
Oncogene
|
February 15, 1996
Inhibition of growth of estrogen receptor positive and estrogen receptor negative breast cancer cells in culture by AA-etherA, a stable 2-5A derivative
K E Latham, S Cosenza, N L Reichenbach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 1, 1994
Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome
R J Suhadolnik, N L Reichenbach, P Hitzges, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1981
Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon
P W Doetsch, R J Suhadolnik, Y Sawada, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 1, 1997
Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome
R J Suhadolnik, D L Peterson, K O'Brien, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Biochemical and Biophysical Research Communications
|
May 31, 1988
Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2b
G E Fronko, R J Suhadolnik, E C Vonderheid, et al.
Biochemistry
|
November 3, 1987
Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease
K Karikó, R W Sobol, L Suhadolnik, et al.
The Journal of Biological Chemistry
|
March 17, 1995
Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2',5'-oligoadenylate derivatives
R W Sobol, E E Henderson, N Kon, et al.
Biochemistry
|
November 16, 1993
HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates
R W Sobol, W L Fisher, N L Reichenbach, et al.
In Vivo (Athens, Greece)
|
July 1, 1994
Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome
R J Suhadolnik, N L Reichenbach, P Hitzges, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1989
Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro
D C Montefiori, R W Sobol, S W Li, et al.
Oncogene
|
February 15, 1996
Inhibition of growth of estrogen receptor positive and estrogen receptor negative breast cancer cells in culture by AA-etherA, a stable 2-5A derivative
K E Latham, S Cosenza, N L Reichenbach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 1, 1994
Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome
R J Suhadolnik, N L Reichenbach, P Hitzges, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1981
Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon
P W Doetsch, R J Suhadolnik, Y Sawada, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 1, 1997
Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome
R J Suhadolnik, D L Peterson, K O'Brien, et al.
Page
of 2